The prerequisites and mechanism in the binding and induced folding of pKID to KIX
The prerequisites and mechanism in the binding and induced folding of pKID to KIX
批准号:
8311686
负责人:
Jamie Paule Ellis
金额:
$5.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-08-01 至 2013-07-31
关键词:
AffinityBindingBinding SitesBiological ModelsBiological ProcessCREB1 geneCalorimetryCarbonChargeChemicalsComplexCoupledCouplingDependenceDevelopmentDiseaseDockingDrug DesignElectrostaticsEvolutionHeartHydrogen BondingHydrophobic InteractionsLeadLengthLigand Binding DomainMYB geneMeasurementMeasuresMethodsModelingMolecularMolecular BiologyMutagenesisMutateNMR SpectroscopyPathway interactionsPeptidesPharmacologic SubstancePhosphotransferasesPhysiologicalPositioning AttributeProteinsProto-Oncogene Proteins c-mybRelative (related person)RelaxationResidual stateRoleRouteSecondary toSeriesSimulateSiteSite-Directed MutagenesisSpecificityStagingStructural ModelsStructureSurfaceTestingThermodynamicsTitrationsTorsionTransactivationTranscriptional RegulationWorkdesignflyinsightintermolecular interactionmolecular dynamicsnovelprotein protein interactionquantumresearch studyrestraintsimulationsmall molecule
中文摘要
蛋白质中普遍存在但知之甚少的内在无序现象对分子生物学的基本问题和新型小分子药物的设计具有广泛的影响。天生无序的蛋白质在生理条件下天生缺乏二级和/或三级结构;它们将折叠与结合结合到相互作用伙伴上,具有高度的特异性,而且往往具有非凡的多功能性。在转录调控、蛋白质相互作用网络和许多疾病的核心都发现了紊乱的特征。迫切需要新的方法来靶向和操纵这些蛋白质-蛋白质相互作用。从选择或遇到中间体到结合形式的详细机制的理解,将导致在控制这些相互作用的小分子的有效设计方面取得重大进展。此外,解决这些小的、高度特异的蛋白质功能的原理将进一步从头设计多肽和模拟物,这是一个日益增长的制药目标。这项工作提出了核磁共振光谱,分子动力学和分子生物学的组合,以获得耦合折叠和结合的独特结构见解。具体地说,这项工作将利用CREB的磷酸化激酶诱导反式激活结构域(PKID)和CBP的KIX结构域作为模型系统来生成沿诱导折叠途径的遭遇复合体和中间体(S)的详细视图。具体地说,这个建议的目的是(1)将二级结构的演变定义为不同于诱导折叠路径中的分子间相互作用,(2)将对接中的飞模效应从静电转向中分离出来,以及(3)产生结合中间体的详细模型(S)。对于目标1,这项工作将利用弛豫色散核磁共振波谱以及羰基和阿尔法碳对二级结构的敏感性来定量中间体中残基的特定螺旋含量(S)。对于目标2,不同长度的pKID结构将被系统地突变,并用等温量热法测量,以分离电荷和结构长度对结合热力学的影响。对于目标3,这项工作将利用核磁共振衍生的限制条件来限制中间体(S)在结合途径中的分子动力学模拟中的扭转角度和相对位置。这些研究的结合将极大地促进我们对内在无序蛋白质关联的基本机制和指导原则的理解。独特的结构洞察力将极大地提高我们设计小分子和多肽以结合和破坏蛋白质-蛋白质相互作用的能力。
英文摘要
The ubiquitous, yet poorly understood, phenomenon of intrinsic disorder in proteins has wide-ranging implications for fundamental questions in molecular biology and the design of novel small molecule pharmaceuticals. Intrinsically disordered proteins inherently lack secondary and/or tertiary structure under physiological conditions; they couple folding with binding to their interaction partners with high specificity and, often, extraordinary versatility. The signatures of disorder are found at the heart of transcriptional regulation, protein interaction networks, and a number of diseases. New methods to target and manipulate these protein-protein interactions are urgently required. Understanding the mechanisms in detail, from selection or encounter through intermediates to the bound form, will lead to significant advances in the efficient design of small molecules to control these interactions. Additionally, resolving the principles governing the function of these small, highly specific proteins will further de novo design of peptides and mimics, a growing pharmaceutical aim. This work proposes a combination of NMR spectroscopy, molecular dynamics and molecular biology to gain unique structural insights into coupled folding and binding. Specifically, this work will utilize the complex of the phosphorylated kinase inducible transactivation domain (pKID) of CREB with the KIX domain of CBP as a model system to generate detailed views of the encounter complex and intermediate(s) along an induced folding pathway. Specifically, this proposal aims to (1) define the evolution of secondary structure as distinct from intermolecular interactions in the induced folding pathway, (2) separate the effect of fly-casting from electrostatic steering in docking, and (3) generate detailed models of the binding intermediate(s). For aim 1, the work will utilize relaxation dispersion NMR spectroscopy and the sensitivity of the carbonyl and alpha carbons to secondary structure to quantify the residue specific helical content in the intermediate(s). For aim 2, pKID constructs of varied lengths will be systematically mutated and measured by isothermal calorimetry to separate the effects of charge and construct length on binding thermodynamics. For aim 3, the work will utilize NMR-derived restraints to limit the torsion angles and relative positions in molecular dynamic simulations of the intermediate(s) in the binding pathway. The combination of these studies will significantly advance our understanding of the fundamental mechanisms and guiding principles in the association of intrinsically disordered proteins. The unique structural insights will greatly increase our ability to design small molecules and peptides to bind and disrupt protein-protein interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The prerequisites and mechanism in the binding and induced folding of pKID to KIX
-
批准号:8003949
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:Jamie Paule Ellis
-
依托单位:
The prerequisites and mechanism in the binding and induced folding of pKID to KIX
-
批准号:8118937
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:Jamie Paule Ellis
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: